Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
December 10, 2024
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
June 15, 2021
Press Releases
CAMP4 Raises $45 Million to Usher in a New Era of Programmable Therapeutics to Upregulate Genes
January 10, 2020
Press Releases
CAMP4 Announces Collaboration to Discover Novel Targets to Address Neurodegenerative and Neurological Diseases
October 29, 2019
Press Releases
CAMP4 Therapeutics Expands Board of Directors with Appointment of Steven Holtzman as Chair and Dr. Paula Ragan as Director
October 25, 2019
Press Releases
Richard Young, Ph.D., Founder of CAMP4 Therapeutics, Elected to National Academy of Medicine
January 23, 2019
Press Releases
CAMP4 Therapeutics Announces Rare Disease Research Collaboration with Alnylam
May 31, 2018
Press Releases
CAMP4 Therapeutics Launches with Platform to Discover Effective Treatment Approaches for Every Disease, Announces $30 Million Series A Financing
«
1
2
3
Media Contact:
PR@camp4tx.com
Top
